1. Introduction and Historical Background
Glycyl-L-histidyl-L-lysine (GHK) is a naturally occurring tripeptide first isolated from human plasma by Pickart and Thaler in 1973. In its copper-bound form, GHK-Cu (copper(II) complex of glycyl-L-histidyl-L-lysine), the peptide has attracted sustained research interest owing to its broad range of observed biological activities in preclinical models. The peptide was initially identified through experiments demonstrating that albumin fractions from young human plasma could stimulate hepatocyte protein synthesis to a degree not achievable by equivalent fractions from older donors, suggesting the presence of a bioactive factor whose concentration declines with age (Pickart, 2008).
GHK is present in human plasma at approximately 200 ng/mL in individuals aged 20-25, declining to approximately 80 ng/mL by age 60. It is also released from extracellular matrix proteins, particularly collagen, following tissue injury. The tripeptide exhibits a strong affinity for copper(II) ions, forming a 1:1 complex at physiological pH with a dissociation constant of approximately 10-16.44 M. This copper-binding characteristic is central to the peptide's proposed mechanisms of action (Pickart, Vasquez-Soltero and Margolina, 2015).
Since its initial characterisation, GHK-Cu has been investigated across multiple research domains including dermatology, wound repair, pulmonary biology, and oncology. The present review examines the current state of preclinical evidence with particular emphasis on molecular mechanisms, skin regeneration, anti-inflammatory properties, and wound healing.
2. Mechanism of Action
2.1 Copper Binding and Delivery
The biological activities of GHK-Cu are understood to depend substantially on its role as a copper-binding and copper-delivery peptide. The histidine and lysine residues within the tripeptide coordinate copper(II) ions in a square planar geometry, enabling stable chelation under physiological conditions while retaining the capacity to transfer copper to cellular uptake systems .
Copper is an essential cofactor for numerous enzymes involved in connective tissue formation, antioxidant defence, and cellular respiration. These include lysyl oxidase (critical for collagen and elastin cross-linking), superoxide dismutase (SOD), and cytochrome c oxidase. By modulating local copper bioavailability, GHK-Cu is hypothesised to influence the activity of these metalloenzymes, thereby affecting downstream processes in tissue remodelling and redox homeostasis (Pickart, Vasquez-Soltero and Margolina, 2015).
2.2 Gene Expression Modulation
Perhaps the most significant area of contemporary GHK-Cu research relates to its capacity to modulate gene expression on a broad scale. Analysis using the Connectivity Map (CMap) database, a reference collection of genome-wide transcriptional expression data from human cell lines treated with bioactive small molecules, revealed that GHK could influence the expression of a substantial number of human genes. Specifically, the peptide was found to modulate 4,096 genes at a statistically significant threshold, representing approximately 31.2% of the genes examined (Pickart, Vasquez-Soltero and Margolina, 2015).
The CMap methodology, originally developed by Lamb et al. (2006) at the Broad Institute, enables the identification of functional connections between drugs, genes, and disease states through gene expression signatures (Lamb et al., 2006). When applied to GHK, this approach revealed upregulation of genes associated with antioxidant response, DNA repair, ubiquitin-proteasome pathways, and extracellular matrix components, alongside downregulation of genes linked to inflammation and tissue destruction (Pickart, Vasquez-Soltero and Margolina, 2015).
Of particular note, Campbell et al. (2012) applied the CMap approach to identify compounds capable of reversing a gene expression signature associated with emphysematous lung destruction. GHK emerged as one of the top-scoring compounds, demonstrating the capacity to reverse the expression pattern of 127 genes associated with emphysema pathology. This finding was significant as it suggested potential relevance of the peptide beyond dermatological applications, pointing toward tissue remodelling processes in pulmonary biology (Campbell et al., 2012).
3. Skin Regeneration Research
The skin regeneration properties of GHK-Cu have been among the most extensively studied aspects of the peptide. In vitro studies have demonstrated that GHK-Cu stimulates collagen synthesis in dermal fibroblast cultures. Maquart et al. (1999) reported that GHK-Cu increased collagen synthesis, while also modulating the expression of both metalloproteinases and their inhibitors (tissue inhibitors of metalloproteinases, or TIMPs), suggesting a dual role in both matrix deposition and controlled remodelling (Maquart et al., 1988).
Beyond collagen, GHK-Cu has been observed to stimulate the synthesis of decorin, a proteoglycan involved in collagen fibril organisation and transforming growth factor-beta (TGF-β) regulation. The peptide has also been reported to promote glycosaminoglycan accumulation, including dermatan sulphate and chondroitin sulphate, which contribute to the hydration and structural integrity of the dermal extracellular matrix (Pickart, 2008).
At the cellular level, Kang et al. (2009) demonstrated that copper-GHK increased integrin expression and p63 positivity in human keratinocytes. Integrins mediate cell-matrix adhesion and signalling, while p63 is a transcription factor associated with the proliferative capacity of basal keratinocytes. These findings suggest that GHK-Cu may influence epidermal regeneration through effects on keratinocyte adhesion and proliferative potential, although the precise signalling cascades remain subjects of ongoing investigation (Kang et al., 2009).
4. Anti-Inflammatory Properties
Inflammatory modulation represents another well-documented activity of GHK-Cu in experimental systems. Gene expression analyses have indicated that GHK suppresses the expression of a number of pro-inflammatory cytokines and mediators. The CMap-based studies revealed that GHK downregulates genes encoding interleukin-6 (IL-6), interleukin-17 (IL-17), and several members of the nuclear factor kappa B (NF-κB) signalling cascade (Pickart, Vasquez-Soltero and Margolina, 2015).
Furthermore, GHK-Cu has been reported to modulate the expression of genes involved in the resolution of inflammation, including the upregulation of anti-inflammatory mediators and antioxidant enzymes. The peptide's influence on superoxide dismutase (SOD) gene expression is of particular interest, as reactive oxygen species (ROS) are both products and drivers of inflammatory tissue damage. By promoting antioxidant gene expression while simultaneously reducing pro-inflammatory signalling, GHK-Cu may contribute to a shift in the local tissue environment from destructive inflammation toward reparative remodelling (Pickart, Vasquez-Soltero and Margolina, 2015).
It is important to note that the majority of anti-inflammatory data for GHK-Cu derives from gene expression profiling and in vitro systems. While these findings are consistent and reproducible, the translation of such observations to complex in vivo inflammatory conditions requires further controlled investigation.
5. Wound Healing Studies
Wound healing has been a central focus of GHK-Cu research since the peptide's early characterisation. The peptide has been investigated in multiple preclinical wound models, with observations including accelerated wound closure, enhanced angiogenesis, increased collagen deposition, and improved tissue organisation at wound sites.
Canapp et al. (2003) evaluated the effect of topical tripeptide-copper complex on healing of ischemic open wounds in a canine model. The study reported that GHK-Cu-treated wounds demonstrated increased epithelialisation, enhanced granulation tissue formation, and improved wound contraction compared with controls, suggesting that the peptide may address aspects of impaired healing associated with ischaemic tissue environments (Canapp et al., 2003).
In a biomaterials approach, Arul et al. (2005) developed biotinylated GHK peptide incorporated into collagenous matrices for application in dermal wound healing in rats. The GHK-incorporated matrices demonstrated enhanced wound closure, improved collagen organisation, and increased hydroxyproline content at wound sites compared with unmodified collagen matrices. These findings suggest potential utility of GHK in biomaterial-based wound management strategies, where sustained delivery of the peptide to the wound microenvironment may augment natural healing cascades (Arul et al., 2005).
The wound healing effects of GHK-Cu are thought to involve multiple concurrent mechanisms: stimulation of fibroblast migration and proliferation, enhancement of extracellular matrix synthesis and remodelling, promotion of angiogenesis through upregulation of vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF), and modulation of the inflammatory phase to facilitate transition toward proliferative repair (Pickart, 2008).
6. Current Research Directions
Contemporary research into GHK-Cu has expanded substantially beyond the peptide's original dermatological context. Several areas of active investigation merit attention.
6.1 Gene Expression and Systems Biology
The application of computational biology tools, particularly the Connectivity Map and related gene expression databases, has opened new avenues for understanding GHK-Cu's broad biological effects. Ongoing analyses continue to identify disease-associated gene expression signatures that may be modulated by GHK, including signatures related to chronic obstructive pulmonary disease, fibrotic conditions, and age-related tissue degeneration (Campbell et al., 2012). These bioinformatic approaches provide hypothesis-generating frameworks that direct subsequent experimental validation.
6.2 Antioxidant and Neuroprotective Research
The capacity of GHK-Cu to modulate antioxidant gene expression has prompted investigation into potential neuroprotective applications. Copper dyshomeostasis and oxidative stress are features of several neurodegenerative conditions, and the ability of GHK-Cu to regulate copper bioavailability while simultaneously promoting antioxidant defences represents an area of emerging research interest. Preclinical studies examining the peptide's effects on neuronal survival and oxidative damage markers are currently ongoing in several research groups (Pickart, Vasquez-Soltero and Margolina, 2015).
6.3 Biomaterial and Delivery System Development
Incorporation of GHK-Cu into advanced delivery systems represents a growing area of translational research. Nanoparticle formulations, hydrogel carriers, electrospun scaffolds, and functionalised wound dressings incorporating GHK-Cu are being developed to achieve sustained and targeted peptide delivery. These approaches seek to overcome the limitations of free peptide administration, including rapid enzymatic degradation and short biological half-life .
6.4 Stem Cell and Regenerative Biology
Emerging evidence suggests that GHK-Cu may influence stem cell behaviour, including the proliferation and differentiation of mesenchymal stem cells. These observations, while preliminary, align with the peptide's documented effects on growth factor expression and extracellular matrix remodelling, and represent a frontier of GHK-Cu research with potential implications for regenerative medicine (Pickart, Vasquez-Soltero and Margolina, 2015).
7. Conclusions
GHK-Cu is a naturally occurring copper-binding tripeptide with a substantial body of preclinical evidence supporting its roles in tissue remodelling, gene expression modulation, anti-inflammatory signalling, and wound repair. The peptide's capacity to influence thousands of human genes, as revealed through connectivity mapping analyses, positions it as a molecule of broad biological interest extending well beyond its original identification as a plasma-derived growth factor.
While the existing literature provides a consistent picture of GHK-Cu's biological activities across multiple experimental systems, it is essential to recognise that the vast majority of evidence derives from in vitro studies, gene expression analyses, and animal wound models. The precise mechanisms by which a single tripeptide exerts such wide-ranging effects remain incompletely understood, and further research employing rigorous controlled methodologies is necessary to elucidate the full scope of GHK-Cu's biological activities.
Continued investigation into GHK-Cu is warranted, particularly in the areas of systems biology, advanced delivery systems, and the emerging connections between copper peptide biology and age-related tissue changes. The peptide's favourable safety profile in preclinical studies, combined with its multi-target biological activity, ensures that it will remain a subject of active research interest across multiple biomedical disciplines.